154 related articles for article (PubMed ID: 15777685)
1. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur.
Nagashima M; Sakai A; Uchida S; Tanaka S; Tanaka M; Nakamura T
Bone; 2005 Mar; 36(3):502-11. PubMed ID: 15777685
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats.
Tanaka M; Sakai A; Uchida S; Tanaka S; Nagashima M; Katayama T; Yamaguchi K; Nakamura T
Bone; 2004 Jun; 34(6):940-8. PubMed ID: 15193540
[TBL] [Abstract][Full Text] [Related]
3. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 selective inhibition suppresses restoration of tibial trabecular bone formation in association with restriction of osteoblast maturation in skeletal reloading after hindlimb elevation of mice.
Nakai K; Tanaka S; Sakai A; Nagashima M; Tanaka M; Otomo H; Nakamura T
Bone; 2006 Jul; 39(1):83-92. PubMed ID: 16487758
[TBL] [Abstract][Full Text] [Related]
5. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
[TBL] [Abstract][Full Text] [Related]
6. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
Yonou H; Ochiai A; Ashimine S; Maeda H; Horiguchi Y; Yoshioka K; Ogawa Y; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(9):999-1009. PubMed ID: 17440967
[TBL] [Abstract][Full Text] [Related]
7. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo.
Aghaloo TL; Amantea CM; Cowan CM; Richardson JA; Wu BM; Parhami F; Tetradis S
J Orthop Res; 2007 Nov; 25(11):1488-97. PubMed ID: 17568450
[TBL] [Abstract][Full Text] [Related]
8. Ethanol extract of Peperomia pellucida (Piperaceae) promotes fracture healing by an anabolic effect on osteoblasts.
Ngueguim FT; Khan MP; Donfack JH; Tewari D; Dimo T; Kamtchouing P; Maurya R; Chattopadhyay N
J Ethnopharmacol; 2013 Jun; 148(1):62-8. PubMed ID: 23578859
[TBL] [Abstract][Full Text] [Related]
9. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
[TBL] [Abstract][Full Text] [Related]
10. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
[TBL] [Abstract][Full Text] [Related]
11. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
13. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
14. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
15. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
[TBL] [Abstract][Full Text] [Related]
16. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle.
McDonald AC; Schuijers JA; Gundlach AL; Grills BL
Bone; 2007 Apr; 40(4):895-903. PubMed ID: 17157570
[TBL] [Abstract][Full Text] [Related]
17. A time course of bone response to jump exercise in C57BL/6J mice.
Umemura Y; Baylink DJ; Wergedal JE; Mohan S; Srivastava AK
J Bone Miner Metab; 2002; 20(4):209-15. PubMed ID: 12115066
[TBL] [Abstract][Full Text] [Related]
18. Drilled hole defects in mouse femur as models of intramembranous cortical and cancellous bone regeneration.
Monfoulet L; Rabier B; Chassande O; Fricain JC
Calcif Tissue Int; 2010 Jan; 86(1):72-81. PubMed ID: 19953233
[TBL] [Abstract][Full Text] [Related]
19. Effects of pleiotrophin (PTN) over-expression on mouse long bone development, fracture healing and bone repair.
Li G; Bunn JR; Mushipe MT; He Q; Chen X
Calcif Tissue Int; 2005 Apr; 76(4):299-306. PubMed ID: 15812580
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
